
Hereditary Spastic Paraplegia 57: Harnessing Genetic Testing for Better Understanding and Management
Explore how genetic testing of the COQ7 gene mutation aids in the diagnosis, management, and family planning of Hereditary Spastic Paraplegia 57.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore how genetic testing of the COQ7 gene mutation aids in the diagnosis, management, and family planning of Hereditary Spastic Paraplegia 57.

Unlock the potential of genetic testing for Hereditary Spastic Paraplegia 61, a rare disorder, through insights into the COQ7 gene variant and personalized care strategies.

Explore how genetic testing aids in diagnosing Hereditary Spastic Paraplegia 62, a condition marked by lower limb weakness, enabling personalized treatment and family planning.

Explore Hereditary Spastic Paraplegia 63, a rare genetic disorder. Learn about genetic testing for early diagnosis, family planning, and personalized treatment.

Explore how genetic testing aids in diagnosing Hereditary Spastic Paraplegia 64, focusing on the COQ7 variant for early intervention and personalized treatment plans.

Unlocking HSP72 insights: genetic testing offers early diagnosis, personalized treatments, informed family planning, and research advancements for better care.

Unlock potential with genetic testing for hyperammonemic encephalopathy. Early diagnosis, tailored treatment, and informed family planning are within reach.

Explore how genetic testing revolutionizes the diagnosis and management of Hyperphosphatasia with Intellectual Disability Syndrome 4, offering insights and personalized care.